Pasireotide diaspartate

• 常用名: Pasireotide diaspartate
• 英文名: Pasireotide diaspartate
• CAS号: 820232-50-6
• 分子量: 1313.412
• 密度: N/A
• 沸点: N/A
• 分子式: C₆₆H₈₀N₁₂O₁₇
• 熔点: N/A
• 闪点: N/A

Pasireotide diaspartate用途

Pasireotide, also known as SOM230, is an orphan drug approved for the treatment of Cushing's disease in patients who fail or are ineligible for surgical therapy. It was developed by Novartis. Pasireotide is a somatostatin analog with a 40-fold increased affinity to somatostatin receptor 5 compared to other somatostatin analogs.

Pasireotide diaspartate名称

• 英文名: Pasireotide diaspartate

Pasireotide diaspartate物理化学性质

• 分子式: C₆₆H₈₀N₁₂O₁₇
• 分子量: 1313.412
• 精确质量: 1312.576416

Pasireotide diaspartate英文别名

• I4P76SY3N4
• L-Aspartic acid, compd. with cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-(phenylmethyl)-L-tyrosyl-L-phenylalanyl-(4R)-4-[[[(2-aminoethyl)amino]carbonyl]oxy]-L-prolyl] (2:1)
• pasireotide aspartate
• Pasireotide diaspartate
• L-Aspartic acid - cyclo[(2S)-2-phenylglycyl-D-tryptophyl-L-lysyl-O-benzyl-L-tyrosyl-L-phenylalanyl-(4R)-4-{[(2-aminoethyl)carbamoyl]oxy}-L-prolyl] (2:1)
• Signifor